Home-brew FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia

被引：23

作者：

Albano, Francesco

Anelli, Luisa

Zagaria, Antonella

Archidiacono, Nicoletta

Liso, Vincenzo

Specchia, Giorgina

Rocchi, Mariano

机构：

[1] Univ Bari, Dept Hematol, Policlin, I-70124 Bari, Italy

[2] Univ Bari, Dipartimento Genet & Microbiol, Policlin, I-70124 Bari, Italy

来源：

CANCER GENETICS AND CYTOGENETICS | 2007年 / 174卷 / 02期

关键词：

D O I：

10.1016/j.cancergencyto.2006.09.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We carried out fluorescence in situ hybridization (FISH) studies on 18 Ph+ chronic myeloid leukemia (CML) cases with chromosome 22 genomic deletions with the Vysis BCR-ABL dual-color/dual-fusion probe (BCR-ABL DC/DF) to compare the hybridization patterns obtained with this approach to those obtained with the "home brew" BAC/PAC system. Our results are the following: chromosome 22 microdeletions less than 400 kilobases (Kb) were not detected by the BCR DC/DF probe; FISH analysis with the BCR DC/DF probe in cases bearing chromosome 22 microdeletions ranging from 400 to 700 Kb produced a faint signal on the der(9); and the BCR-ABL DC/DF FISH pattern was comparable to the one obtained by the home brew probe in the presence of a 900-Kb chromosome 22 microdeletion. Our home-brew FISH system represents an accurate method for revealing a subset of CML patients with der(9) microdeletions. (c) 2007 Elsevier Inc. All rights reserved.

引用

收藏

页码：121 / 126

页数：6

相关论文

共 18 条

[1] Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases [J].

Albano, F ;

Specchia, G ;

Anelli, L ;

Zagaria, A ;

Storlazzi, CT ;

Buquicchio, C ;

Roberti, MG ;

Liso, V ;

Rocchi, M .

GENES CHROMOSOMES & CANCER, 2003, 36 (04) :353-360

[2] Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis [J].

Aoun, P ;

Wiggins, M ;

Pickering, D ;

Foran, J ;

Rasheed, H ;

Pavletic, SZ ;

Sanger, W .

CANCER GENETICS AND CYTOGENETICS, 2004, 154 (02) :138-143

[3] Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene:: expression profiling, resistance to interferon therapy, and poor prognosis [J].

Cohen, N ;

Rozenfeld-Granot, G ;

Hardan, I ;

Brok-Simoni, F ;

Amariglio, N ;

Rechavi, G ;

Trakhtenbrot, L .

CANCER GENETICS AND CYTOGENETICS, 2001, 128 (02) :114-119

[4] Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions [J].

Huntly, BJP ;

Guilhot, F ;

Reid, AG ;

Vassiliou, G ;

Hennig, E ;

Franke, C ;

Byrne, J ;

Brizard, A ;

Niederwieser, D ;

Freeman-Edward, J ;

Cuthbert, G ;

Bown, N ;

Clark, RE ;

Nacheva, EP ;

Green, AR ;

Deininger, MWN .

BLOOD, 2003, 102 (06) :2205-2212

[5] Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia [J].

Huntly, BJP ;

Bench, A ;

Green, AR .

BLOOD, 2003, 102 (04) :1160-1168

[6] Derivative chromosome 9 deletions in chronic myeloid leukemia:: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability [J].

Huntly, BJP ;

Bench, AJ ;

Delabesse, E ;

Reid, AG ;

Li, J ;

Scott, MA ;

Campbell, L ;

Byrne, J ;

Pinto, E ;

Brizard, A ;

Niedermeiser, D ;

Nacheva, EP ;

Guilhot, F ;

Deininger, M ;

Green, AR .

BLOOD, 2002, 99 (12) :4547-4553

[7] Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia [J].

Huntly, BJP ;

Reid, AG ;

Bench, AJ ;

Campbell, LJ ;

Telford, N ;

Shepherd, P ;

Szer, J ;

Prince, HM ;

Turner, P ;

Grace, C ;

Nacheva, EP ;

Green, AR .

BLOOD, 2001, 98 (06) :1732-1738

[8] Cytogenetic and molecular genetic evolution of chronic myeloid leukemia [J].

Johansson, B ;

Fioretos, T ;

Mitelman, F .

ACTA HAEMATOLOGICA, 2002, 107 (02) :76-94

[9] Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis [J].

Kolomietz, E ;

Al-Maghrabi, J ;

Brennan, S ;

Karaskova, J ;

Minkin, S ;

Lipton, J ;

Squire, JA .

BLOOD, 2001, 97 (11) :3581-3588

[10] HIGH-RESOLUTION MAPPING OF HUMAN CHROMOSOME-11 BY INSITU HYBRIDIZATION WITH COSMID CLONES [J].

LICHTER, P ;

TANG, CJC ;

CALL, K ;

HERMANSON, G ;

EVANS, GA ;

HOUSMAN, D ;

WARD, DC .

SCIENCE, 1990, 247 (4938) :64-69